Potential of Adult Stem Cells Discussed
Posted on: Monday, 17 March 2008, 12:00 CDT
U.S. drug companies are making significant progress behind the scenes in harvesting the potential uses of adult stem cells and preparing to market them.
Representatives of a number of companies met with institutional investors in New York recently to discuss a science that is projected to yield $87 million in drug sales this year alone, The Chicago Tribune reported Monday.
Unlike their embryonic counterparts, adult stem cells are not controversial and face much lower regulatory hurdles, the newspaper says.
The U.S. Food and Drug Administration has already developed regulations to deal with the coming rush of adult stem cell products from drug and device producers.
In the pipeline are devices to extract a patient's own adult stem cells from fat tissue and a drug to repair gastrointestinal damage caused by radiation.
Currently stem cell products are being sold to treat rare blood disorders, repair hips, reconstruct jaws and infuse spines.
They are the building blocks that theoretically can be manipulated to perform the work of many other cell types.
Source: United Press International
Related Articles
- Scientists Turn Adult Skin Cells Into Muscle And Vice Versa
- Nanoparticle 'Smart Bomb' Targets Drug Delivery to Cancer Cells
- Cytori Selected By Fraunhofer Society to Develop New Stem and Regenerative Cell-Based Treatments for Stroke
- First Three Patients Treated in Adipose Stem and Regenerative Cell Clinical Safety and Feasibility Study for Breast Reconstruction; Represents First Clinical Use of Cytori's Regenerative Cell Processing System
- Cytori Therapeutics Reports Benefit of Adipose Stem and Regenerative Cells in Reconstructive Surgery From Preclinical Study
- Clinical Safety and Feasibility Study Initiated Using Adipose Stem and Regenerative Cells in Breast Reconstruction Procedures
- PharmaFrontiers to Present Data on Adult Human T-Cell and Stem Cell Technologies at the International Society for Cellular Therapy Annual Meeting
- ProtoKinetix AAGP(TM) Cosmetic Applications Enhanced By Preservation of Adult Skin Cells
- MultiCell Enters into a Joint Venture With Living Cell Technologies to Develop Adult Liver Cell Technologies for Drug Discovery, Protein Production and Therapeutic Clinical Applications
- Adult Skin Cell 'Reprogrammed' to Stem Cell
 |
 |
User Comments (0)
RSS Feeds